5TH ANNUAL RALLY WILL BE HELD SEPT 22TH, 2012
5th ANNUAL RALLY FOR ALI
IN SEARCH OF A CURE FOR DIABETES
ALL DONATIONS WILL GO TO HARVARD STEM CELL INSTITUTE
PICNIC FOR A CAUSE
KRAUSE’S GROVE, 2 Beach Road, Halfmoon, NY
SATURDAY, SEPTEMBER 21, 2013
1:00 PM TO 6:00 PM ~ RAIN OR SHINE
$30.00 per adult ticket at gate - $20.00 for children under 12
includes donation to Harvard Stem Cell Institute.
5 hour picnic with soda, beer, games, raffles, 50/50, live music
JAMBONE - THE BEAR BONES PROJECT - BLUE HAND LUKE
SPECIAL GUEST APPEARANCE BY AWARD-WINNING IRISH STEP DANCER
GRACE CATHERINE MOMROW (Ali’s cousin)
Abundant food and dessert being served 1:00 p.m. to 5:00 p.m.
Those who wish to join a pre-picnic motorcycle cavalcade around the beautiful Tomhannock Reservoir in Ali’s honor will meet at the Troy Plaza on Hoosick Street at 10:00 A.M. for sign up and the cavalcade will kick off at 11:00 A.M. sharp.
For more info: https://www.facebook.com/Rally4Ali
For Further Information
For the Run, Wally Urzan
For the Picnic & Cause
Saturday, October 30, 2010
REPRINT OR LICENSE
DUBLIN -- Maven Semantic (http://www.mavensemantic.com) announces updates to their Cancer Stem Cell research database.
The new database is now available to marketing, business development, competitor intelligence, KOL, medical affairs and related departments in the life sciences sector.
The database currently tags 47,000 individuals working in Cancer Stem Cell. http://bit.ly/cDtRZO .
Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample. CSCs are therefore tumorigenic (tumor-forming), perhaps in contrast to other non-tumorigenic cancer cells. CSCs may generate tumors through the stem cell processes of self-renewal and differentiation into multiple cell types. Such cells are proposed to persist in tumors as a distinct population and cause relapse and metastasis by giving rise to new tumors. Therefore, development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of life of cancer patients, especially for sufferers of metastatic disease.
Top 10 Countries for Cancer Stem Cell Research (ranked by number of senior Cancer Stem Cell researchers)
. United States Of America (19,200)
. Japan (4,447)
. Germany (3,100)
. United Kingdom (2,437)
. Italy (2,164)
. Canada (1,680)
. France (1,629)
. China (1,484)
. The Netherlands (968)
. Australia (843)
Leading organisations in Cancer Stem Cell research include:
. Harvard Medical School
. National Institutes of Health
. University of California
. Memorial Sloan-Kettering Cancer Center
. Fred Hutchinson Cancer Research Center
. National Cancer Institute
. Dana-Farber Cancer Institute
. Duke University Medical Center
. Washington University School of Medicine
. Baylor College of Medicine
. Indiana University School of Medicine
. Stanford University School of Medicine
. The University of Texas M. D. Anderson Cancer Center
. Massachusetts General Hospital
. Kyoto University
. Terry Fox Laboratory
. University of Cambridge
. University of Pennsylvania
. St. Jude Children's Research Hospital
. Karolinska Institutet
. Leiden University Medical Center
. Osaka University
. Medical College of Wisconsin
. Keio University
. University of Ulm
The database also includes pharmaceutical companies, biotech companies, CROs, hospitals, government labs and other organisations active in the Cancer Stem Cell research field.
Read more: http://www.sunherald.com/2010/10/29/2594199/maven-semantic-cancer-stem-cell.html#ixzz13rED3KyK
Monday, October 11, 2010
(CBS/AP) A California bio-tech company has begun testing an embryonic stem-cell drug treatment on a patient with spinal cord injuries, marking the first time a drug made with embryonic stem cells has been used on a human.
The patient was enrolled at Shepherd Center, a spinal cord and brain injury rehabilitation center in Atlanta.
In order to participate, the patient had to have been injured within the last two weeks. The company, Geron, hopes to enroll another eight to 10 patients in the study.
The stem-cell drug, known as GRNOPC, contains cells that turn into oligodendrocytes, a type of cell that produces myelin, a coating that allows impulses to move along nerves.
When those cells are lost because of injury, paralysis can follow. If GRNOPC1 works, the progenitor cells will produce new oligodendrocytes in the injured area of the patient's spine, potentially allowing for new movement.
Because this is an early stage study, researchers are primarily concerned with the safety of the treatment.
"When we started working with human embryonic stem cells in 1999, many predicted that it would be a number of decades before a cell therapy would be approved for human clinical trials," Dr. Thomas B. Okarma, president and chief executive officer of Geron said in a statement.
Embryonic stem cells have been at the center of funding controversies because the research involves destroying human embryos, which some have argued is akin to abortion.
But, many researchers consider embryonic stem cells the most versatile types of stem cells, as they can morph into any type of cell.
While a milestone in the technology, the drug is still a long way from being proven and reaching the market. It still faces many years of testing for effectiveness if all goes well in the early stage study.
Thursday, October 7, 2010
CDSMC Rides with Big Boys
Hi Everyone ~
Capital District Scooter and Moped Club Rides With The Big Boys attached. Love it.
Our thanks to Arthur "Jerry" Dunn for bringing his club into the Rally for Ali ride this year. Our picnic for a Cause is in search of a cure for diabetes with all donations going to Harvard Stem Cell Institute and we thank the members of the club for attending the Rally and for their donations to the Cause. We understand that they thought the Rally was great and Jerry will try to bring even more club members to ride in the Rally next September.
They had 13 scooters; 10 made the full journey. The ones that did stay with the bikes had a great time and two that couldn't keep up, made it to the Rally by a different route, anyway.
Of the 10 that made it all the way 4 did not come into the Rally, and instead sent checks totaling $120.00 to Jerry for the Cause which I received yesterday and will be forwarding their checks along with all the rest to HSCI with our covering letter.
We certainly look forward to seeing CDSMC again at the Rally next September at Krause's. They were a great addition. Thanks again guys!
p.s. We had 80 more people attend the Rally this year than last year, thanks to the very hard work of the Rally for Ali Committee. That additional number is just fantastic and Ali's family really, REALLY, appreciates the Committees wonderful dedication to the Cause and for their unswerving loyal support of our beautiful little Ali. She LIVES. She continues to Rock On! And so do we.